Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M29.5Revenue $M0.1Net Margin (%)-11,451.1Altman Z-Score-11.5
Enterprise Value $M20.6EPS $-0.1Operating Margin %-12,518.8Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-11,451.1Higher ROA y-yY
Price/Book1.510-y EBITDA Growth Rate %-11.3Quick Ratio3.8Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %-4.1Current Ratio4.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-54.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-62.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M248ROIC % (ttm)-159.4Gross Margin Increase y-yN

Gurus Latest Trades with HEB

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

HEB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


HEB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Equels Thomas K.CEO,Pres,Exec Vice Chairman 2016-03-18Buy30,000$0.13-7.69view
Equels Thomas K.CEO,Pres,Exec Vice Chairman 2016-03-11Buy40,000$0.16-25view
Equels Thomas K.CEO,Pres,Exec Vice Chairman 2016-03-11Buy40,000$0.16-25view
Equels Thomas K.CEO,Pres,Exec Vice Chairman 2016-03-10Buy30,000$0.16-25view
Equels Thomas K.CEO,Pres,Exec Vice Chairman 2016-03-10Buy30,000$0.16-25view
CARTER WILLIAM ACEO, 10% Owner 2015-08-20Buy25,000$0.18-33.33view
CARTER WILLIAM ACEO, 10% Owner 2015-08-18Buy25,000$0.18-33.33view
CARTER WILLIAM ACEO, 10% Owner 2015-08-17Buy25,000$0.18-33.33view
Equels Thomas K.CFO, Pres.,Sec., Vice Chairman 2015-08-14Buy79,104$0.18-33.33view
CARTER WILLIAM ACEO, 10% Owner 2015-04-28Buy100,000$0.24-50view

Quarterly/Annual Reports about HEB:

News about HEB:

Articles On GuruFocus.com
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-K/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q) Nov 08 2010 
Weekly CEO Sells Highlight: Hemispherx Biopharma Inc, ADESA Inc, Entergy Corp, and Danaher Corp. Aug 15 2010 
Hemispherx Biopharma Inc Reports Operating Results (10-Q) Aug 06 2010 
Hemispherx Biopharma Inc (HEB) CEO William A Carter buys 500,000 Shares Jul 01 2010 
Weekly CFO Buys Highlight: Wireless Telecom Group, ValueVision Media, American River Bankshares, Hem Dec 12 2009 
Hemispherx Biopharma Inc (HEB) CFO Charles Thomas Iii Bernhardt buys 2,000 Shares Dec 08 2009 

More From Other Websites
Hemispherx Biopharma Retains Huron Consulting Group to Support Partnering Strategy and Planning for... Apr 20 2016
Hemispherx Biopharma Retains Huron Consulting Group to Support Partnering Strategy and Planning for... Apr 20 2016
Hemispherx signs deal with Saudi Arabian drug company Apr 05 2016
Hemispherx Biopharma Enters into Alfa-n3 Interferon Clinical Trial, Sales, Marketing, Distribution,... Apr 04 2016
Hemispherx Biopharma Enters into Alfa-n3 Interferon Clinical Trial, Sales, Marketing, Distribution,... Apr 04 2016
HEMISPHERX BIOPHARMA INC Financials Apr 02 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement Apr 01 2016
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2015 Apr 01 2016
Hemispherx Biopharma Reviews Ampligen® Data with National Institute of Neurological Disorders and... Apr 01 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 30 2016
HEMISPHERX BIOPHARMA ANNOUNCES FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2015 Hemispherx... Mar 30 2016
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2015 Mar 29 2016
HEMISPHERX BIOPHARMA INC Files SEC form 10-K, Annual Report Mar 29 2016
Hemispherx Biopharma Announces Conference Call to Discuss Management Changes and Provide Corporate... Mar 22 2016
Hemispherx Biopharma Announces Conference Call to Discuss Management Changes and Provide Corporate... Mar 22 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Mar 16 2016
Hemispherx Biopharma Reviews Ampligen® Data With National Institute of Neurological Disorders and... Mar 10 2016
Hemispherx Biopharma, Inc. (NYSEMKTS: HEB) With New Management Comes New Opportunity Mar 02 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 01 2016
Struggling Philadelphia biotech firm gets new CEO Feb 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)